Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis
Antelman, S.M.; Chiodo, L.A.
Biological Psychiatry 16(8): 717-727
1981
ISSN/ISBN: 0006-3223 PMID: 7197169 Document Number: 176091
Electrophysiological studies demonstrating that a variety of antidepressants depression and the induction of amphetamine psychosis.
Document emailed within 1 workday
Related Documents
Antelman, S.M.; Chiodo, L.A. 1981: Repeated antidepressant treatments induce a long-lasting dopamine autoreceptor subsensitivity: is daily treatment necessary for clinical efficacy? Psychopharmacology Bulletin 17(1): 92-94Hjorth, S.; Jackson, D.; Carlsson, A.; Lindberg, P. 1982: A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP Psychopharmacology Bulletin 18(4): 149-152
Leelahanaj, T.; Kongsakon, R.; Netrakom, P. 2005: A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis Journal of the Medical Association of Thailand 88(Suppl 3): S43-S52
Gangadhar, B.N.; Pradhan, N.; Mayanil, C.S. 1987: Dopamine autoreceptor down-regulation following repeated electroconvulsive shock Indian Journal of Medical Research 86: 787-791
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Okuyama, S.; Shimamura, H.; Hashimoto, S.; Aihara, H. 1986: Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats Archives Internationales de Pharmacodynamie et de Therapie 284(2): 246-254
Kuczenski, R.; Segal, D.S. 1992: Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine Journal of Pharmacology and Experimental Therapeutics 262(3): 1085-1094
Parker, E.M.; Cubeddu, L.X. 1986: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores Journal of Pharmacology and Experimental Therapeutics 237(1): 179-192
Glick, R.L.; Ghaemi, S.N. 2000: The emergency treatment of depression complicated by psychosis or agitation Journal of Clinical Psychiatry 61(Suppl 14): 43-48
Kallenbach, R.J. 1983: The induction of de novo centrioles in sea urchin eggs: a possible common mechanism for centriolar activation among parthenogenetic procedures European Journal of Cell Biology 30(2): 159-166
Ettigi, P.G.; Hayes, P.E.; Narasimhachari, N.; Hamer, R.M.; Goldberg, S.; Secord, G.J. 1983: D-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression Biological Psychiatry 18(4): 499-504
Holsten, F. 1975: STP--(DOM), a psychomimetic amphetamine with hallucinogenic and psychosis-inducing properties Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(4): 234-237
Bijak, M. 1997: Imipramine-induced subsensitivity to the 5-HT4 receptor activation, a possible mediation via an alteration in the postreceptor transduction mechanism involving adenylate cyclase Polish Journal of Pharmacology 49(5): 345-350
Krüger, R.; Weiss, D. 2011: Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease MMW Fortschritte der Medizin 153(14): 29-32; Quiz 33
Jacocks, H.M.; Cox, B.M. 1992: Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine Journal of Pharmacology and Experimental Therapeutics 262(1): 356-364
Nutt, D.J. 2006: The role of dopamine and norepinephrine in depression and antidepressant treatment Journal of Clinical Psychiatry 67(Suppl 6): 3-8
Kikuchi, T.; Tottori, K.; Uwahodo, Y.; Hirose, T.; Miwa, T.; Oshiro, Y.; Morita, S. 1995: 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity Journal of Pharmacology and Experimental Therapeutics 274(1): 329-336
Di Chiara, G. 1991: On the preferential release of mesolimbic dopamine by amphetamine Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 5(4): 243-247
Baker, W.W.; Zivanovic, D.; Malseed, R.T. 1976: Tremorogenic effects of intracaudate d-amphetamine and their suppression by dopamine Archives Internationales de Pharmacodynamie et de Therapie 223(2): 271-281
Durán-Ferreras, E.; Alvarez-López, M.; García-Moreno, J.M.; Chacón, J. 2008: Ziprasidone in Parkinsonian dopamine psychosis Revista de Neurologia 46(8): 476-480